Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial.

Dieter Naber; Andrew Greenspan; Andreas Schreiner

Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial.

Standard

Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial. / Naber, Dieter; Greenspan, Andrew; Schreiner, Andreas.

In: PSYCHOPHARMACOLOGY, Vol. 191, No. 4, 4, 2007, p. 1027-1029.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Naber, D, Greenspan, A & Schreiner, A 2007, 'Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial.', PSYCHOPHARMACOLOGY, vol. 191, no. 4, 4, pp. 1027-1029. <http://www.ncbi.nlm.nih.gov/pubmed/17333131?dopt=Citation>

APA

Naber, D., Greenspan, A., & Schreiner, A. (2007). Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial. PSYCHOPHARMACOLOGY, 191(4), 1027-1029. [4]. http://www.ncbi.nlm.nih.gov/pubmed/17333131?dopt=Citation

Vancouver

Naber D, Greenspan A, Schreiner A. Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial. PSYCHOPHARMACOLOGY. 2007;191(4):1027-1029. 4.

Bibtex

@article{f51ef243e87a49ab8bc732a3d6311a6b,

title = "Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial.",

author = "Dieter Naber and Andrew Greenspan and Andreas Schreiner",

year = "2007",

language = "Deutsch",

volume = "191",

pages = "1027--1029",

journal = "PSYCHOPHARMACOLOGY",

issn = "0033-3158",

publisher = "Springer",

number = "4",

}

RIS

TY - JOUR

T1 - Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial.

AU - Naber, Dieter

AU - Greenspan, Andrew

AU - Schreiner, Andreas

PY - 2007

Y1 - 2007

M3 - SCORING: Zeitschriftenaufsatz

VL - 191

SP - 1027

EP - 1029

JO - PSYCHOPHARMACOLOGY

JF - PSYCHOPHARMACOLOGY

SN - 0033-3158

IS - 4

M1 - 4

ER -